New research is bringing us closer to understanding how gut health may be tied to Parkinson’s disease, one of the world’s most common and disabling neurodegenerative conditions.
A major international study led by scientists from the Quadram Institute and EMBL has found consistent and significant changes in the gut microbiome of people with Parkinson’s, using data from nearly 4,500 patients across 22 studies.
Published in Nature Communications, the study is the most detailed analysis yet of how gut bacteria differ in Parkinson’s patients compared to healthy individuals.
Researchers applied machine learning—a form of artificial intelligence—to scan through mountains of data and uncover patterns linking specific microbes and their activities to the disease.
Parkinson’s is well known for causing motor symptoms like shaking, stiffness, and slowness. But less widely recognized are the gut problems that often start decades earlier—such as constipation, inflammation, and increased intestinal “leakiness.”
These early digestive issues have led scientists to explore the gut microbiome, the vast community of bacteria living in our digestive system, as a possible key to unlocking the mysteries of the disease.
Previous studies have shown that people with Parkinson’s tend to have different gut bacteria than healthy people. But because of different methods and varying populations, those results were hard to compare. This new research helps overcome those barriers by merging and analyzing data from around the world.
One of the study’s most fascinating discoveries was a pattern of gut bacteria involved in breaking down xenobiotics—chemicals foreign to the human body, such as pesticides, solvents, and pollutants.
These substances have long been suspected as possible environmental triggers for Parkinson’s. Finding their signature in the gut microbes of patients adds strong support to that theory.
“It’s intriguing that the microbiome of people with Parkinson’s shows an enhanced ability to process these environmental chemicals,” said Dr. Stefano Romano, lead author of the study. “It suggests that these individuals may have had more contact with these toxins, or that their gut microbes have been changed by them.”
Senior author Dr. Georg Zeller added, “We don’t yet know whether this microbial activity makes these chemicals more or less harmful—but it’s a promising direction for future research.”
Beyond chemical processing, the study also identified signs of inflammation and bacterial activity typically associated with infections. This suggests that the gut lining in Parkinson’s patients may be more permeable—commonly known as a “leaky gut.”
When the gut barrier breaks down, bacterial toxins and possibly harmful chemicals can move into the bloodstream, and potentially reach the brain, contributing to nerve damage.
Still, some caution is needed. It’s not yet clear whether the gut microbiome changes cause Parkinson’s or are a result of the disease—or even of the medications used to treat it. Scientists also don’t know exactly which xenobiotics may be involved, or how they interact with gut microbes to affect brain health.
Even so, this study marks an important step forward. The machine learning models trained on this global data were far better at identifying Parkinson’s-related microbiome changes than models trained on smaller, single studies. That gives researchers a more reliable map of the gut changes associated with Parkinson’s across different populations and environments.
Dr. Romano noted, “We’ve now created the most up-to-date picture of the gut microbiome differences seen in Parkinson’s disease—both in terms of which bacteria are present and what they do.”
Dr. Arjan Narbad of the Quadram Institute emphasized the broader promise: “Gut microbiome variation makes it hard to pinpoint which microbes matter most, but by combining machine learning and large datasets, we’re laying the groundwork for new ways to diagnose, monitor, and potentially treat Parkinson’s.”
In short, this research offers new insights into how gut health and environmental exposures may influence brain diseases. While more work is needed to understand the underlying mechanisms, this large-scale study highlights the gut microbiome’s growing importance in the search for Parkinson’s treatments—and even prevention strategies.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
The research findings can be found in Nature Communications.
Copyright © 2025 Knowridge Science Report. All rights reserved.
